Extracellular matrix alterations in hypertensive vascular remodeling.
暂无分享,去创建一个
[1] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[2] P. Libby,et al. Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease , 2009, Circulation.
[3] H. Jo,et al. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. , 2007, American journal of physiology. Heart and circulatory physiology.
[4] P. Carmeliet,et al. Temporal and Topographic Matrix Metalloproteinase Expression after Vascular Injury in Mice , 1999, Thrombosis and Haemostasis.
[5] Albert Hofman,et al. Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.
[6] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[7] Stefan Störk,et al. Carotid Artery Plaque Burden, Stiffness, and Mortality Risk in Elderly Men: A Prospective, Population-Based Cohort Study , 2004, Circulation.
[8] AlainTedgui,et al. Pulsatile Stretch–Induced Extracellular Signal–Regulated Kinase 1/2 Activation in Organ Culture of Rabbit Aorta Involves Reactive Oxygen Species , 2000 .
[9] A. Tedgui,et al. Signal transduction of mechanical stresses in the vascular wall. , 1998, Hypertension.
[10] Ali A Haydar,et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. , 2004, Kidney international.
[11] J. Díez,et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. , 1998, Circulation.
[12] D. Kass,et al. Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[13] H. van Essen,et al. Determination of Aortic Elastic Modulus by Pulse Wave Velocity and Wall Tracking in a Rat Model of Aortic Stiffness , 2001, Journal of Vascular Research.
[14] D. Seals,et al. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. , 2003, Genes & development.
[15] A. Pries,et al. Microcirculation in Hypertension: A New Target for Treatment? , 2001, Circulation.
[16] K. Brew,et al. Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.
[17] R. Guldberg,et al. Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice , 2002, The Journal of experimental medicine.
[18] K. Hruska,et al. Bone Morphogenetic Proteins in Vascular Calcification , 2005, Circulation research.
[19] V. Tkachuk,et al. Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture. , 1997, Circulation research.
[20] N. Fukuda,et al. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. , 1999, Journal of hypertension.
[21] A. Tedgui,et al. Role of Matrix Metalloproteinases in Early Hypertensive Vascular Remodeling , 2007, Hypertension.
[22] M. Gorospe,et al. Acute hypertension activates mitogen-activated protein kinases in arterial wall. , 1996, The Journal of clinical investigation.
[23] B. Sobel,et al. Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1). , 2004, The American journal of cardiology.
[24] A. Tedgui,et al. Pressure-Induced Matrix Metalloproteinase-9 Contributes to Early Hypertensive Remodeling , 2004, Circulation.
[25] T. Haas,et al. Static strain stimulates expression of matrix metalloproteinase‐2 and VEGF in microvascular endothelium via JNK‐ and ERK‐dependent pathways , 2007, Journal of cellular biochemistry.
[26] B. Pannier,et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. , 2001, Kidney international.
[27] P. Ducimetiere,et al. Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.
[28] L. Demer. A skeleton in the atherosclerosis closet. , 1995, Circulation.
[29] Edward G Lakatta,et al. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.
[30] M. Matsumoto,et al. Associations of Brachial-Ankle Pulse Wave Velocity and Carotid Atherosclerotic Lesions with Silent Cerebral Lesions , 2007, Hypertension Research.
[31] J. Thyberg,et al. Phenotypic Modulation of Smooth Muscle Cells after Arterial Injury Is Associated with Changes in the Distribution of Laminin and Fibronectin , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] I. Wilkinson,et al. ARTERIAL STIFFNESS, ENDOTHELIAL FUNCTION AND NOVEL PHARMACOLOGICAL APPROACHES , 2004, Clinical and experimental pharmacology & physiology.
[33] Huan Wang,et al. The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin–angiotensin system in vivo , 2004, Journal of hypertension.
[34] M. Daemen,et al. Cathepsin cysteine proteases in cardiovascular disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] S. Morony,et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. , 1998, Genes & development.
[36] G. London. Large arteries haemodynamics: conduit versus cushioning function. , 1997, Blood pressure. Supplement.
[37] J. McEwan,et al. Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.
[38] E. Mannarino,et al. Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension , 2006, Hypertension.
[39] Y. Castier,et al. Role of NF-kappaB in flow-induced vascular remodeling. , 2009, Antioxidants & redox signaling.
[40] E. Lakatta,et al. Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.
[41] C. Rondelli,et al. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. , 2007, American journal of physiology. Heart and circulatory physiology.
[42] Anne-Sophie Rigaud,et al. Relationship Between Arterial Stiffness and Cognitive Function in Elderly Subjects With Complaints of Memory Loss , 2005, Stroke.
[43] Robert M. Graham,et al. Transglutaminases: crosslinking enzymes with pleiotropic functions , 2003, Nature Reviews Molecular Cell Biology.
[44] L. Romanowicz,et al. Preeclampsia-associated reduction of cathepsin D activity in the umbilical cord. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[45] D. Vaughan,et al. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. , 2002, Journal of molecular and cellular cardiology.
[46] M. Laule,et al. Downregulation of Matrix Metalloproteinases and Collagens and Suppression of Cardiac Fibrosis by Inhibition of the Proteasome , 2004, Hypertension.
[47] Jay D. Humphrey,et al. Time Courses of Growth and Remodeling of Porcine Aortic Media During Hypertension: A Quantitative Immunohistochemical Examination , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[48] Robert T Tranquillo,et al. Elastic fiber production in cardiovascular tissue-equivalents. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[49] A. Tedgui,et al. Pressure-Induced Vascular Activation of Nuclear Factor-&kgr;B: Role in Cell Survival , 2003, Circulation research.
[50] Avrum I. Gotlieb,et al. Wall Tissue Remodeling Regulates Longitudinal Tension in Arteries , 2002, Circulation research.
[51] K. Fujiwara,et al. ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.
[52] P. Toutouzas,et al. Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment , 2003, Journal of Human Hypertension.
[53] London Gm. Large arteries haemodynamics: conduit versus cushioning function. , 1997 .
[54] R. Terkeltaub,et al. Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells , 2008, Circulation research.
[55] T. Hunter,et al. Focal Adhesion Kinase Overexpression Enhances Ras-dependent Integrin Signaling to ERK2/Mitogen-activated Protein Kinase through Interactions with and Activation of c-Src* , 1997, The Journal of Biological Chemistry.
[56] Roger D. Kamm,et al. Mechanotransduction through growth-factor shedding into the extracellular space , 2004, Nature.
[57] Z. Ungvari,et al. Regulation of Bone Morphogenetic Protein-2 Expression in Endothelial Cells , 2005 .
[58] Z. Ungvari,et al. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. , 2004, The American journal of pathology.
[59] Shunqiang Li,et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach , 2005, Nature Medicine.
[60] N. Winer,et al. Vascular compliance in hypertension: Therapeutic implications , 2008, Current diabetes reports.
[61] J. Blacher,et al. Conventional Antihypertensive Drug Therapy Does Not Prevent the Increase of Pulse Pressure With Age , 2001, Hypertension.
[62] Attila Kovacs,et al. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. , 2003, The Journal of clinical investigation.
[63] A. Clowes,et al. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[64] A. Tedgui,et al. Transforming Growth Factor- Mediates Nuclear Factor B Activation in Strained Arteries , 2006 .
[65] A. Cho,et al. Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury , 2002, Circulation research.
[66] Michael F O'Rourke,et al. Arterial aging: pathophysiological principles , 2007, Vascular medicine.
[67] A. Tedgui,et al. Differential Regulation of Vascular Focal Adhesion Kinase by Steady Stretch and Pulsatility , 2005, Circulation.
[68] M. Aoki,et al. Hypertension Accelerated Experimental Abdominal Aortic Aneurysm Through Upregulation of Nuclear Factor &kgr;B and Ets , 2006, Hypertension.
[69] A. D'Angelo,et al. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. , 2006, Endothelium : journal of endothelial cell research.
[70] R. Nemenoff,et al. Activation of JNK/SAPK and ERK by mechanical strain in vascular smooth muscle cells depends on extracellular matrix composition. , 1997, Biochemical and biophysical research communications.
[71] A. Newby,et al. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. , 2005, Physiological reviews.
[72] N Westerhof,et al. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. , 1995, Journal of hypertension.
[73] Gillian Murphy,et al. Metalloproteinase inhibitors: biological actions and therapeutic opportunities , 2002, Journal of Cell Science.